Cite

HARVARD Citation

    Wu, J. et al. (2020). A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension. Medicine. 99 (32), p. . [Online]. 
  
Back to record